Insider Trading › CTLT › Insiders
CTLT
CTLT·Insider activity
—
No end-of-day price on record
CTLT
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
CTLTS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of CTLT were filed in the last 180 days. Newest filing Nov 14, 2024 (1 year ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by CTLT insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
308Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of CTLT common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
308 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Ryan Michelle RDirector | Sale | −2,800 | $59.70 | $167K | 10.8Kdirect | Nov 11, 2024 | Nov 14, 2024 | Form 4 ↗ |
| Ferraro Joseph AnthonySVP, General Counsel, CCO | Sale | −320 | $59.97 | $19K | 24.0Kdirect | Oct 18, 2024 | Oct 21, 2024 | Form 4 ↗ |
| McErlane DavidGroup President, Biologics | Sale | −1,994 | $59.97 | $120K | 36.3Kdirect | Sep 26, 2024 | Sep 27, 2024 | Form 4 ↗ |
| Hopson RickyPres. BioProduct Delivery, CoS | Sale | −662 | $59.56 | $39K | 30.0Kdirect | Aug 2, 2024 | Aug 5, 2024 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −666 | $59.55 | $40K | 39.6Kdirect | Aug 2, 2024 | Aug 5, 2024 | Form 4 ↗ |
| Ferraro Joseph AnthonySVP, General Counsel, CCO | Sale | −608 | $59.58 | $36K | 24.3Kdirect | Aug 2, 2024 | Aug 5, 2024 | Form 4 ↗ |
| Evoli LisaSVP, Chief HR Officer | Sale | −3,859 | $59.67 | $230K | 39.4Kdirect | Aug 2, 2024 | Aug 5, 2024 | Form 4 ↗ |
| Gennadios AristipposGroup Pres. Pharma & Consumer | Sale | −1,169 | $59.55 | $70K | 113.7Kdirect | Aug 2, 2024 | Aug 5, 2024 | Form 4 ↗ |
| Maselli AlessandroPresident & CEO · Director | Sale | −9,088 | $58.76 | $534K | 177.5Kdirect | Jul 29, 2024 | Jul 30, 2024 | Form 4 ↗ |
| Hopson RickyPres. BioProduct Delivery, CoS | Sale | −206 | $58.67 | $12K | 30.6Kdirect | Jul 29, 2024 | Jul 30, 2024 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −283 | $58.69 | $17K | 40.3Kdirect | Jul 29, 2024 | Jul 30, 2024 | Form 4 ↗ |
| Gennadios AristipposGroup Pres. Pharma & Consumer | Sale | −349 | $58.70 | $20K | 114.9Kdirect | Jul 29, 2024 | Jul 30, 2024 | Form 4 ↗ |
| Masanovich MattiSVP, Chief Financial Officer | Sale | −2,993 | $56.74 | $170K | 33.9Kdirect | Jul 8, 2024 | Jul 10, 2024 | Form 4 ↗ |
| Hopson RickyPres. BioProduct Delivery, CoS | Sale | −1,401 | $54.26 | $76K | 20.6Kdirect | Jun 4, 2024 | Jun 5, 2024 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −387 | $56.20 | $22K | 29.5Kdirect | Mar 15, 2024 | Mar 19, 2024 | Form 4 ↗ |
| Ryan Michelle RDirector | Purchase | +1,000 | $49.98 | $50K | 1,979direct | Aug 31, 2023 | Sep 5, 2023 | Form 4 ↗ |
| GREISCH JOHN JExecutive Chair · Director | Purchase | +21.0K | $50.24 | $1.1M | 34.0Kindirect | Aug 30, 2023 | Sep 1, 2023 | Form 4 ↗ |
| Maselli AlessandroPresident & CEO · Director | Sale | −101 | $45.15 | $5K | 88.0Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Maselli AlessandroPresident & CEO · Director | Sale | −1,970 | $44.51 | $88K | 88.1Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −269 | $44.57 | $12K | 29.9Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −390 | $44.50 | $17K | 24.4Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Gennadios AristipposGroup Pres. Pharma & Consumer | Sale | −396 | $44.49 | $18K | 96.6Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Fasman Steven LEVP & Chief Admin Officer | Sale | −817 | $44.65 | $36K | 73.8Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Carletti LorenzoSVP Global Ops Ph & Cons Hlth | Sale | −216 | $44.71 | $10K | 8,746direct | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Arnold JonathanSVP, CCO & Div. Head BioP Del. | Sale | −87 | $44.87 | $4K | 57.4Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Hopson RickyPres. Clinical Dev Supply Div | Sale | −276 | $44.56 | $12K | 22.0Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Hawkeswood Thomas WPres. Pharma Prod Delivery Div | Sale | −147 | $44.72 | $7K | 7,533direct | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Lickfold CharlesSVP, CIO | Sale | −190 | $44.72 | $8K | 11.3Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Hunt PatriciaPres. Consumer Health Div | Sale | −106 | $44.77 | $5K | 11.3Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Pravda RicardoChief Transformation Officer | Sale | −379 | $44.47 | $17K | 30.2Kdirect | Aug 24, 2023 | Aug 25, 2023 | Form 4 ↗ |
| Pravda RicardoChief Transformation Officer | Sale | −222 | $47.78 | $11K | 19.7Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Pravda RicardoChief Transformation Officer | Sale | −47 | $46.50 | $2K | 20.0Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Maselli AlessandroPresident & CEO · Director | Sale | −606 | $47.75 | $29K | 86.1Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Maselli AlessandroPresident & CEO · Director | Sale | −879 | $46.71 | $41K | 86.7Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Lickfold CharlesSVP, CIO | Sale | −135 | $47.90 | $6K | 5,570direct | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Hunt PatriciaPres. Consumer Health Div | Sale | −161 | $47.95 | $8K | 9,154direct | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Hopson RickyPres. Clinical Dev Supply Div | Sale | −195 | $47.86 | $9K | 16.3Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Hawkeswood Thomas WPres. Pharma Prod Delivery Div | Sale | −258 | $47.97 | $12K | 5,106direct | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −190 | $47.90 | $9K | 23.8Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −241 | $47.88 | $12K | 17.5Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −35 | $46.64 | $2K | 17.8Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Gennadios AristipposGroup Pres. Pharma & Consumer | Sale | −220 | $47.87 | $11K | 86.5Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Gennadios AristipposGroup Pres. Pharma & Consumer | Sale | −61 | $46.58 | $3K | 86.7Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Carletti LorenzoSVP Global Ops Ph & Cons Hlth | Sale | −383 | $47.77 | $18K | 4,602direct | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Arnold JonathanSVP, CCO & Div. Head BioP Del. | Sale | −62 | $47.80 | $3K | 55.9Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Fasman Steven LEVP & Chief Admin Officer | Sale | −524 | $47.76 | $25K | 60.2Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Fasman Steven LEVP & Chief Admin Officer | Sale | −1,113 | $46.72 | $52K | 60.7Kdirect | Aug 1, 2023 | Aug 3, 2023 | Form 4 ↗ |
| Boerman ManjaPres. BioModalities Division | Sale | −1,446 | $49.86 | $72K | 14.4Kdirect | May 1, 2023 | May 3, 2023 | Form 4 ↗ |
| Gargiulo MarioSVP, Ops, Biologics Europe | Sale | −678 | $49.86 | $34K | 5,676direct | May 1, 2023 | May 3, 2023 | Form 4 ↗ |
| Hopson RickyPres. Clinical Dev Supply Div | Sale | −643 | $49.36 | $32K | 16.5Kdirect | Jan 23, 2023 | Jan 25, 2023 | Form 4 ↗ |
| Boerman ManjaPres. BioModalities Division | Sale | −780 | $51.70 | $40K | 15.9Kdirect | Dec 5, 2022 | Dec 7, 2022 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −2,451 | $65.83 | $161K | 17.8Kdirect | Oct 31, 2022 | Nov 2, 2022 | Form 4 ↗ |
| Hawkeswood Thomas WPres. Pharma Prod Delivery Div | Sale | −930 | $77.46 | $72K | 5,364direct | Oct 10, 2022 | Oct 12, 2022 | Form 4 ↗ |
| Hopson RickyPres. Clinical Dev Supply Div | Sale | −2,216 | $89.59 | $199K | 17.1Kdirect | Aug 31, 2022 | Sep 2, 2022 | Form 4 ↗ |
| Riley Michael A.Pres. Bio Product Delivery Div | Sale | −2,491 | $104.07 | $259K | 6,592direct | Aug 26, 2022 | Aug 30, 2022 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −1,639 | $104.07 | $171K | 24.0Kdirect | Aug 26, 2022 | Aug 30, 2022 | Form 4 ↗ |
| Schmidt Kay ASVP, Enterprise Functions | Sale | −1,321 | $103.04 | $136K | 17.4Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Riley Michael A.Pres. Bio Product Delivery Div | Sale | −1,482 | $103.04 | $153K | 9,083direct | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −1,747 | $103.04 | $180K | 20.0Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Maselli AlessandroPresident & CEO · Director | Sale | −4,646 | $103.04 | $479K | 41.2Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Hunt PatriciaPres. Consumer Health Div | Sale | −339 | $103.04 | $35K | 9,315direct | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Hopson RickyPres. Clinical Dev Supply Div | Sale | −1,517 | $103.04 | $156K | 19.3Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Hawkeswood Thomas WPres. Pharma Prod Delivery Div | Sale | −671 | $103.04 | $69K | 6,294direct | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −1,840 | $103.04 | $190K | 25.6Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −1,670 | $103.04 | $172K | 20.2Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Gennadios AristipposGroup Pres. Pharma & Consumer | Sale | −1,645 | $103.04 | $170K | 86.8Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Gargiulo MarioSVP Global Ops Biologics | Sale | −1,586 | $103.04 | $163K | 6,354direct | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Fasman Steven LEVP & Chief Admin Officer | Sale | −4,811 | $103.04 | $496K | 61.9Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Chiminski John RExecutive Chair · Director | Sale | −38.9K | $103.04 | $4.0M | 229.9Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Castellano Thomas PSVP, Chief Financial Officer | Sale | −1,414 | $103.04 | $146K | 20.1Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Carletti LorenzoSVP Global Ops Ph & Cons Hlth | Sale | −1,033 | $103.04 | $106K | 4,985direct | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Boerman ManjaPres. BioModalities Division | Sale | −3,296 | $103.04 | $340K | 16.6Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Arnold JonathanSVP & Chief Commercial Ofcr | Sale | −384 | $103.04 | $40K | 56.0Kdirect | Aug 25, 2022 | Aug 26, 2022 | Form 4 ↗ |
| Hopson RickyPres, Clinical Dev & Supply | Sale | −591 | $107.67 | $64K | 17.1Kdirect | Jul 27, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −394 | $107.67 | $42K | 22.4Kdirect | Jul 27, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −388 | $107.67 | $42K | 17.0Kdirect | Jul 27, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Schmidt Kay ASVP, Enterprise Functions | Sale | −323 | $106.90 | $35K | 13.5Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −427 | $106.90 | $46K | 15.3Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Maselli AlessandroPresident & CEO · Director | Sale | −816 | $106.90 | $87K | 25.1Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Hopson RickyPres, Clinical Dev & Supply | Sale | −312 | $106.90 | $33K | 17.0Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −450 | $106.90 | $48K | 21.6Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −409 | $106.90 | $44K | 16.1Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Gennadios AristipposGroup Pres. Pharma & Consumer | Sale | −403 | $106.90 | $43K | 79.8Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Gargiulo MarioSVP Global Ops Biologics | Sale | −969 | $106.90 | $104K | 3,671direct | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Fasman Steven LEVP & Chief Admin Officer | Sale | −2,546 | $106.90 | $272K | 53.7Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Chiminski John RExecutive Chair · Director | Sale | −9,691 | $106.90 | $1.0M | 132.4Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Castellano Thomas PSVP, Chief Financial Officer | Sale | −347 | $106.90 | $37K | 15.1Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Carletti LorenzoSVP Global Ops Ph & Cons Hlth | Sale | −631 | $106.90 | $67K | 2,949direct | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Arnold JonathanSVP & Chief Commercial Ofcr | Sale | −94 | $106.90 | $10K | 48.7Kdirect | Jul 26, 2022 | Jul 28, 2022 | Form 4 ↗ |
| Gargiulo MarioSVP Global Ops Large Molecule | Sale | −118 | $106.59 | $13K | 4,640direct | Jun 10, 2022 | Jun 13, 2022 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −1,951 | $107.54 | $210K | 56.2Kdirect | Jun 10, 2022 | Jun 13, 2022 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −3,049 | $106.77 | $326K | 58.1Kdirect | Jun 10, 2022 | Jun 13, 2022 | Form 4 ↗ |
| Zippelius PeterDirector | Sale | −487.1K | $102.65 | $50.0M | 4.3Mindirect | Feb 6, 2022 | Feb 8, 2022 | Form 4 ↗ |
| Hopson RickyVP, Chief Accounting Officer | Sale | −2,325 | $103.39 | $240K | 17.1Kdirect | Jan 31, 2022 | Feb 1, 2022 | Form 4 ↗ |
| Whitlow Ricci SPresident, CSS | Sale | −184 | $102.37 | $19K | 2,923direct | Jan 21, 2022 | Jan 24, 2022 | Form 4 ↗ |
| Flynn KarenChief Commercial Officer | Sale | −2,472 | $116.64 | $288K | 33.2Kdirect | Jan 10, 2022 | Jan 11, 2022 | Form 4 ↗ |
| Director | Sale | −3.0M | $129.30 | $387.9M | 4.8Mindirect | Nov 30, 2021 | Dec 1, 2021 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Sale | −2,400 | $127.76 | $307K | 0indirect | Nov 23, 2021 | Nov 24, 2021 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Sale | −2,668 | $126.98 | $339K | 2,400indirect | Nov 23, 2021 | Nov 24, 2021 | Form 4 ↗ |
| Arnold JonathanPres. Oral & Specialty Deliv. | Sale | −10.7K | $140.02 | $1.5M | 42.0Kdirect | Nov 1, 2021 | Nov 3, 2021 | Form 4 ↗ |
| Castellano Thomas PSVP, Chief Financial Officer | Sale | −2,307 | $134.00 | $309K | 15.4Kdirect | Oct 20, 2021 | Oct 21, 2021 | Form 4 ↗ |
| Arnold JonathanPres. Oral & Specialty Deliv. | Sale | −1,661 | $129.41 | $215K | 45.1Kdirect | Oct 14, 2021 | Oct 18, 2021 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −2,191 | $131.25 | $288K | 13.8Kdirect | Oct 4, 2021 | Oct 6, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −1,800 | $131.04 | $236K | 57.1Kdirect | Oct 4, 2021 | Oct 6, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −4,192 | $130.39 | $547K | 58.9Kdirect | Oct 4, 2021 | Oct 6, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −8,209 | $129.17 | $1.1M | 63.1Kdirect | Oct 4, 2021 | Oct 6, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −20.5K | $128.56 | $2.6M | 71.3Kdirect | Oct 4, 2021 | Oct 6, 2021 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −4,906 | $132.68 | $651K | 11.7Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −1,339 | $132.56 | $177K | 12.5Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −416 | $131.14 | $55K | 13.8Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −100 | $129.05 | $13K | 14.3Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −200 | $128.00 | $26K | 14.4Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −4,888 | $132.86 | $649K | 142.1Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −64.0K | $132.18 | $8.5M | 147.0Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −26.7K | $131.21 | $3.5M | 211.0Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −21.2K | $130.39 | $2.8M | 237.7Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −12.7K | $129.22 | $1.6M | 258.9Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −18.5K | $128.10 | $2.4M | 271.6Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −4,601 | $127.34 | $586K | 290.1Kdirect | Oct 1, 2021 | Oct 5, 2021 | Form 4 ↗ |
| Castellano Thomas PSVP, Chief Financial Officer | Sale | −1,935 | $131.20 | $254K | 17.7Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Castellano Thomas PSVP, Chief Financial Officer | Sale | −158 | $130.29 | $21K | 19.6Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −762 | $131.20 | $100K | 16.0Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −63 | $130.29 | $8K | 16.7Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Hopson RickyVP, Chief Accounting Officer | Sale | −1,360 | $131.20 | $178K | 19.4Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Hopson RickyVP, Chief Accounting Officer | Sale | −111 | $130.29 | $14K | 20.8Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −639 | $131.20 | $84K | 12.8Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −53 | $130.29 | $7K | 13.5Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Maselli AlessandroPresident & COO | Sale | −3,460 | $131.20 | $454K | 25.9Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Maselli AlessandroPresident & COO | Sale | −283 | $130.29 | $37K | 29.4Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −1,878 | $130.34 | $245K | 18.1Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −2,122 | $131.20 | $278K | 19.9Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −173 | $130.29 | $23K | 22.1Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −1,570 | $131.20 | $206K | 14.6Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −128 | $130.29 | $17K | 16.1Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Gennadios AristipposPresident Softgel & Oral Tech | Sale | −2,091 | $131.20 | $274K | 57.5Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Gennadios AristipposPresident Softgel & Oral Tech | Sale | −171 | $130.29 | $22K | 59.6Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −5,650 | $131.20 | $741K | 74.6Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −461 | $130.29 | $60K | 80.2Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −40.9K | $131.12 | $5.4M | 229.9Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −3,600 | $130.41 | $469K | 270.8Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Arnold JonathanPres. Oral & Specialty Deliv. | Sale | −417 | $131.20 | $55K | 46.7Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Arnold JonathanPres. Oral & Specialty Deliv. | Sale | −35 | $130.29 | $5K | 47.2Kdirect | Aug 27, 2021 | Aug 30, 2021 | Form 4 ↗ |
| Castellano Thomas PSVP, Chief Financial Officer | Sale | −555 | $113.05 | $63K | 14.5Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −547 | $113.05 | $62K | 13.3Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Hopson RickyVP, Chief Accounting Officer | Sale | −360 | $113.05 | $41K | 16.1Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −458 | $113.05 | $52K | 10.6Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Maselli AlessandroPresident & COO | Sale | −993 | $113.05 | $112K | 18.6Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −470 | $113.02 | $53K | 15.4Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −609 | $113.05 | $69K | 15.9Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −451 | $113.05 | $51K | 16.6Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Gennadios AristipposPresident Softgel & Oral Tech | Sale | −465 | $113.05 | $53K | 50.9Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −1,549 | $113.05 | $175K | 67.4Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −11.1K | $113.05 | $1.3M | 152.5Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Arnold JonathanPres. Oral & Specialty Deliv. | Sale | −120 | $113.05 | $14K | 38.5Kdirect | Jul 26, 2021 | Jul 28, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −1,187 | $110.46 | $131K | 68.9Kdirect | Jul 15, 2021 | Jul 16, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −3,313 | $109.64 | $363K | 70.1Kdirect | Jul 15, 2021 | Jul 16, 2021 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −2,800 | $110.58 | $310K | 11.1Kdirect | Jun 23, 2021 | Jun 24, 2021 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −1,400 | $105.77 | $148K | 13.9Kdirect | Mar 22, 2021 | Mar 23, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −800 | $107.07 | $86K | 163.6Kdirect | Mar 19, 2021 | Mar 22, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −111.6K | $106.24 | $11.9M | 164.4Kdirect | Mar 19, 2021 | Mar 22, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −70.6K | $105.64 | $7.5M | 276.1Kdirect | Mar 19, 2021 | Mar 22, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −8,732 | $104.96 | $917K | 73.3Kdirect | Mar 18, 2021 | Mar 22, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −12.9K | $104.24 | $1.3M | 82.0Kdirect | Mar 18, 2021 | Mar 22, 2021 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −42.2K | $105.16 | $4.4M | 163.6Kdirect | Mar 18, 2021 | Mar 22, 2021 | Form 4 ↗ |
| Joseph WettenySVP & Chief Financial Officer | Sale | −1,000 | $127.00 | $127K | 49.8Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Joseph WettenySVP & Chief Financial Officer | Sale | −1,001 | $126.13 | $126K | 50.8Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Joseph WettenySVP & Chief Financial Officer | Sale | −1,200 | $123.73 | $148K | 51.8Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Joseph WettenySVP & Chief Financial Officer | Sale | −1,799 | $122.82 | $221K | 53.0Kdirect | Feb 16, 2021 | Feb 18, 2021 | Form 4 ↗ |
| Joseph WettenySVP & Chief Financial Officer | Sale | −4,604 | $113.73 | $524K | 49.8Kdirect | Feb 8, 2021 | Feb 10, 2021 | Form 4 ↗ |
| Whitlow Ricci SPresident, CSS | Sale | −692 | $118.85 | $82K | 2,576direct | Jan 21, 2021 | Jan 25, 2021 | Form 4 ↗ |
| Flynn KarenPres. Biologics & CCO | Sale | −1,100 | $112.50 | $124K | 34.5Kdirect | Jan 11, 2021 | Jan 11, 2021 | Form 4 ↗ |
| Flynn KarenPres. Biologics & CCO | Sale | −1,378 | $112.14 | $155K | 35.6Kdirect | Jan 11, 2021 | Jan 11, 2021 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −61 | $104.78 | $6K | 16.5Kdirect | Jan 6, 2021 | Jan 7, 2021 | Form 4 ↗ |
| Whitlow Ricci SPresident, CSS | Sale | −83 | $104.42 | $9K | 3,268direct | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −73 | $104.42 | $8K | 15.3Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −78 | $104.42 | $8K | 13.9Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Maselli AlessandroPresident & COO | Sale | −148 | $104.42 | $15K | 19.6Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Joseph WettenySVP & Chief Financial Officer | Sale | −172 | $104.42 | $18K | 54.4Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −120 | $104.42 | $13K | 16.6Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −126 | $104.42 | $13K | 17.1Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Gennadios AristipposPresident Softgel & Oral Tech | Sale | −110 | $104.42 | $11K | 51.3Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Flynn KarenPres. Biologics & CCO | Sale | −99 | $104.42 | $10K | 37.0Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −189 | $104.42 | $20K | 73.3Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Arnold JonathanPres. Oral & Specialty Deliv. | Sale | −16 | $104.42 | $2K | 38.6Kdirect | Jan 4, 2021 | Jan 5, 2021 | Form 4 ↗ |
| Gennadios AristipposPresident Softgel & Oral Tech | Sale | −9,726 | $102.80 | $1.0M | 51.4Kdirect | Dec 21, 2020 | Dec 23, 2020 | Form 4 ↗ |
| Gennadios AristipposPresident Softgel & Oral Tech | Sale | −3,936 | $102.95 | $405K | 51.4Kdirect | Dec 21, 2020 | Dec 23, 2020 | Form 4 ↗ |
| Zippelius PeterDirector | Sale | −5.4M | $99.26 | $535.2M | 0indirect | Nov 23, 2020 | Nov 25, 2020 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −2,425 | $100.99 | $245K | 73.5Kdirect | Nov 11, 2020 | Nov 12, 2020 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −200 | $94.87 | $19K | 15.8Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −900 | $94.18 | $85K | 16.0Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −700 | $92.88 | $65K | 16.9Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Schmidt Kay ASVP, Technical Operations | Sale | −1,185 | $92.23 | $109K | 17.6Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −500 | $94.33 | $47K | 75.9Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −568 | $92.28 | $52K | 76.4Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −353 | $92.95 | $33K | 77.0Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −100 | $94.89 | $9K | 77.3Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −1,400 | $94.29 | $132K | 77.4Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −100 | $92.88 | $9K | 78.8Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −2,489 | $92.31 | $230K | 78.9Kdirect | Oct 14, 2020 | Oct 16, 2020 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −1,680 | $94.99 | $160K | 17.2Kdirect | Oct 12, 2020 | Oct 13, 2020 | Form 4 ↗ |
| Arnold JonathanPres. Oral & Specialty Deliv. | Sale | −15.9K | $91.50 | $1.5M | 38.6Kdirect | Oct 7, 2020 | Oct 9, 2020 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −49 | $86.22 | $4K | 16.7Kdirect | Oct 2, 2020 | Oct 5, 2020 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −1,645 | $84.94 | $140K | 16.7Kdirect | Oct 2, 2020 | Oct 5, 2020 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −2,665 | $85.80 | $229K | 18.4Kdirect | Oct 2, 2020 | Oct 5, 2020 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −173.0K | $86.05 | $14.9M | 173.6Kdirect | Oct 2, 2020 | Oct 5, 2020 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −9,191 | $85.27 | $784K | 346.7Kdirect | Oct 2, 2020 | Oct 5, 2020 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −6 | $90.00 | $540 | 18.9Kdirect | Sep 2, 2020 | Sep 8, 2020 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −2,244 | $89.50 | $201K | 18.9Kdirect | Sep 2, 2020 | Sep 8, 2020 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Sale | −24.0K | $90.09 | $2.2M | 16.9Kdirect | Jul 30, 2020 | Aug 3, 2020 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −400 | $72.58 | $29K | 13.4Kdirect | Jun 29, 2020 | Jul 1, 2020 | Form 4 ↗ |
| Gunther ScottSVP, Quality & Reg. Affairs | Sale | −2,424 | $71.90 | $174K | 13.8Kdirect | Jun 29, 2020 | Jul 1, 2020 | Form 4 ↗ |
| Gennadios AristipposPresident Softgel & Oral Tech | Sale | −8,325 | $73.00 | $608K | 44.5Kdirect | Jun 25, 2020 | Jun 29, 2020 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Purchase | +2,000 | $59.71 | $119K | 40.9Kdirect | Feb 13, 2020 | Feb 14, 2020 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −1,680 | $58.00 | $97K | 11.6Kdirect | Jan 13, 2020 | Aug 23, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −2,406 | $56.00 | $135K | 13.3Kdirect | Dec 20, 2019 | Aug 23, 2021 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −1,846 | $54.00 | $100K | 15.7Kdirect | Dec 19, 2019 | Aug 23, 2021 | Form 4 ↗ |
| Maselli AlessandroPresident & COO | Sale | −7,268 | $53.18 | $387K | 12.8Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −1,315 | $52.74 | $69K | 10.8Kdirect | Nov 26, 2019 | Nov 27, 2019 | Form 4 ↗ |
| Pravda RicardoSVP & Chief HR Officer | Sale | −1,297 | $52.71 | $68K | 12.2Kdirect | Nov 26, 2019 | Nov 27, 2019 | Form 4 ↗ |
| Gennadios AristipposPresident Softgel & Oral Tech | Sale | −45.3K | $52.55 | $2.4M | 44.2Kdirect | Nov 25, 2019 | Nov 27, 2019 | Form 4 ↗ |
| Grippo Michael JSVP, Strategy & Corp. Dev. | Sale | −376 | $52.00 | $20K | 10.7Kdirect | Nov 22, 2019 | Nov 26, 2019 | Form 4 ↗ |
| Chiminski John RChair & CEO · Director | Sale | −97.0K | $48.84 | $4.7M | 224.3Kdirect | Oct 7, 2019 | Oct 9, 2019 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Purchase | +2,000 | $51.64 | $103K | 38.9Kdirect | Sep 9, 2019 | Sep 11, 2019 | Form 4 ↗ |
| Littlejohns BarryPresident, Biologics & SDD | Sale | −100 | $54.29 | $5K | 37.7Kdirect | Jul 12, 2019 | Jul 16, 2019 | Form 4 ↗ |
| Littlejohns BarryPresident, Biologics & SDD | Sale | −15.8K | $53.53 | $848K | 37.8Kdirect | Jul 12, 2019 | Jul 16, 2019 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −4,053 | $54.04 | $219K | 48.5Kdirect | Jul 11, 2019 | Jul 15, 2019 | Form 4 ↗ |
| BUZY PETER LPresident, Gene Therapy | Purchase | +44.5K | $45.13 | $2.0M | 44.5Kdirect | May 29, 2019 | May 30, 2019 | Form 4 ↗ |
| MOREL DONALD E JRDirector | Purchase | +10.0K | $44.44 | $444K | 47.0Kdirect | May 15, 2019 | May 16, 2019 | Form 4 ↗ |
| LUCIER GREGORY TDirector | Purchase | +2,000 | $45.08 | $90K | 38.8Kdirect | May 9, 2019 | May 13, 2019 | Form 4 ↗ |
| Gennadios AristipposPresident, Softgel Tech. | Sale | −66 | $42.91 | $3K | 34.7Kdirect | Mar 21, 2019 | Mar 25, 2019 | Form 4 ↗ |
| Gennadios AristipposPresident, Softgel Tech. | Sale | −3,326 | $42.17 | $140K | 34.8Kdirect | Mar 21, 2019 | Mar 25, 2019 | Form 4 ↗ |
| Miyamoto LanceSVP, Human Resources | Sale | −119 | $42.55 | $5K | 46.8Kdirect | Mar 7, 2019 | Mar 11, 2019 | Form 4 ↗ |
| Miyamoto LanceSVP, Human Resources | Sale | −43.5K | $42.49 | $1.8M | 46.9Kdirect | Mar 7, 2019 | Mar 11, 2019 | Form 4 ↗ |
| Downie WilliamSVP, Global Sales & Marketing | Sale | −7,315 | $42.00 | $307K | 34.9Kdirect | Feb 15, 2019 | Feb 20, 2019 | Form 4 ↗ |
| GREISCH JOHN JDirector | Purchase | +13.0K | $37.61 | $489K | 13.0Kindirect | Nov 8, 2018 | Nov 13, 2018 | Form 4 ↗ |
| Miyamoto LanceSVP, Human Resources | Sale | −6,525 | $42.50 | $277K | 46.8Kdirect | Oct 16, 2018 | Oct 18, 2018 | Form 4 ↗ |
| Littlejohns BarryPresident, Biologics & SDD | Sale | −47.3K | $41.64 | $2.0M | 37.7Kdirect | Oct 15, 2018 | Oct 17, 2018 | Form 4 ↗ |
| Chiminski John RChair, President & CEO · Director | Sale | −130.5K | $45.32 | $5.9M | 229.7Kdirect | Oct 1, 2018 | Oct 3, 2018 | Form 4 ↗ |
| MOREL DONALD E JRDirector | Purchase | +10.0K | $43.00 | $430K | 37.0Kdirect | Sep 13, 2018 | Sep 17, 2018 | Form 4 ↗ |
| Fasman Steven LSVP & General Counsel | Sale | −2,252 | $41.78 | $94K | 43.3Kdirect | Jun 20, 2018 | Jun 21, 2018 | Form 4 ↗ |
| Downie WilliamSVP, Global Sales & Marketing | Sale | −9,082 | $41.80 | $380K | 35.4Kdirect | Mar 8, 2018 | Mar 12, 2018 | Form 4 ↗ |
| Chiminski John RChair, President & CEO · Director | Sale | −78.2K | $39.51 | $3.1M | 230.1Kdirect | Dec 12, 2017 | Dec 13, 2017 | Form 4 ↗ |
| Chiminski John RChair, President & CEO · Director | Sale | −21.8K | $39.70 | $866K | 308.3Kdirect | Dec 11, 2017 | Dec 13, 2017 | Form 4 ↗ |
| Chiminski John RChair, President & CEO · Director | Sale | −81.5K | $39.70 | $3.2M | 330.1Kdirect | Dec 11, 2017 | Dec 13, 2017 | Form 4 ↗ |
| Roehrhoff UweDirector | Purchase | +7,500 | $39.22 | $294K | 16.5Kdirect | Nov 21, 2017 | Nov 22, 2017 | Form 4 ↗ |
| Miyamoto LanceSVP - Human Resources | Sale | −8,512 | $38.22 | $325K | 41.1Kdirect | Aug 29, 2017 | Aug 31, 2017 | Form 4 ↗ |
| Dolan ChristineSVP - Product Development | Sale | −1,594 | $38.75 | $62K | 19.4Kdirect | Aug 29, 2017 | Aug 31, 2017 | Form 4 ↗ |
| Dolan ChristineSVP - Product Development | Sale | −745 | $34.85 | $26K | 14.1Kdirect | Aug 1, 2017 | Aug 3, 2017 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −2,759 | — | — | 93.7Kdirect | Jun 9, 2017 | Jun 12, 2017 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −25.0K | — | — | 96.5Kdirect | Jun 8, 2017 | Jun 12, 2017 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −736 | $29.00 | $21K | 30.8Kdirect | Apr 25, 2017 | Apr 27, 2017 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −825 | $29.00 | $24K | 30.1Kdirect | Apr 25, 2017 | Apr 27, 2017 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −891 | $29.00 | $26K | 29.3Kdirect | Apr 25, 2017 | Apr 27, 2017 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −224 | $29.00 | $6K | 28.4Kdirect | Apr 25, 2017 | Apr 27, 2017 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −366 | $29.00 | $11K | 28.2Kdirect | Apr 25, 2017 | Apr 27, 2017 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −60 | $29.00 | $2K | 27.8Kdirect | Apr 25, 2017 | Apr 27, 2017 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −5,204 | $29.00 | $151K | 27.7Kdirect | Apr 25, 2017 | Apr 27, 2017 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −854 | $29.00 | $25K | 22.5Kdirect | Apr 25, 2017 | Apr 27, 2017 | Form 4 ↗ |
| Downie WilliamSee Remarks | Sale | −955 | $28.60 | $27K | 36.7Kdirect | Mar 20, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Downie WilliamSee Remarks | Sale | −770 | $28.60 | $22K | 35.7Kdirect | Mar 20, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Downie WilliamSee Remarks | Sale | −5,792 | $28.60 | $166K | 34.9Kdirect | Mar 20, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Downie WilliamSee Remarks | Sale | −171 | $28.60 | $5K | 29.1Kdirect | Mar 20, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Downie WilliamSee Remarks | Sale | −574 | $28.60 | $16K | 29.0Kdirect | Mar 20, 2017 | Mar 22, 2017 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −201 | $28.76 | $6K | 186.5Kdirect | Mar 20, 2017 | Mar 20, 2017 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −4,784 | $28.58 | $137K | 186.7Kdirect | Mar 16, 2017 | Mar 20, 2017 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −68.8K | $28.62 | $2.0M | 191.5Kdirect | Mar 16, 2017 | Mar 20, 2017 | Form 4 ↗ |
| MOREL DONALD E JRDirector | Purchase | +10.0K | $29.27 | $293K | 18.8Kdirect | Feb 15, 2017 | Feb 16, 2017 | Form 4 ↗ |
| Blackstone Group L.P.10% owner | Sale | −17.1M | $23.58 | $403.2M | 0indirect | Sep 9, 2016 | Sep 13, 2016 | Form 4 ↗ |
| Blackstone Group Management L.L.C.10% owner | Sale | −8.8M | $24.51 | $215.3M | 17.1Mindirect | Jun 9, 2016 | Jun 13, 2016 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −3,524 | $28.85 | $102K | 88.2Kdirect | May 27, 2016 | Jun 1, 2016 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −13.3K | $28.85 | $382K | 88.2Kdirect | May 27, 2016 | Jun 1, 2016 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −4,418 | $28.85 | $127K | 88.2Kdirect | May 27, 2016 | Jun 1, 2016 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −2,955 | $33.93 | $100K | 340.1Kdirect | Aug 19, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −35.5K | $33.80 | $1.2M | 343.1Kdirect | Aug 17, 2015 | Aug 19, 2015 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −35.3K | $33.85 | $1.2M | 340.1Kdirect | Aug 3, 2015 | Aug 5, 2015 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −15.6K | $31.18 | $487K | 84.1Kdirect | Jul 27, 2015 | Jul 29, 2015 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −6,436 | $31.18 | $201K | 84.1Kdirect | Jul 27, 2015 | Jul 29, 2015 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −5,116 | $31.18 | $160K | 84.1Kdirect | Jul 27, 2015 | Jul 29, 2015 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −19.0K | $29.40 | $559K | 340.1Kdirect | Jul 20, 2015 | Jul 22, 2015 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −14.1K | $29.40 | $413K | 340.1Kdirect | Jul 20, 2015 | Jul 22, 2015 | Form 4 ↗ |
| Chiminski John RSee Remarks · Director | Sale | −33.8K | $29.34 | $993K | 340.1Kdirect | Jul 6, 2015 | Jul 8, 2015 | Form 4 ↗ |
| Blackstone Group L.P.10% owner | Sale | −1.8M | n/c | — | 25.9Mindirect | Jun 11, 2015 | Jun 11, 2015 | Form 4 ↗ |
| Blackstone Group Management L.L.C.10% owner | Sale | −12.3M | n/c | — | 27.7Mindirect | Jun 8, 2015 | Jun 10, 2015 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −32.4K | $30.43 | $987K | 84.1Kdirect | Apr 6, 2015 | Apr 8, 2015 | Form 4 ↗ |
| WALSH MATTHEW MSee Remarks | Sale | −2,000 | $30.43 | $61K | 82.5Kdirect | Apr 6, 2015 | Apr 8, 2015 | Form 4 ↗ |
| Houlton ScottSee Remarks | Sale | −575 | $30.61 | $18K | 34.1Kdirect | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Houlton ScottSee Remarks | Sale | −851 | $30.61 | $26K | 33.4Kdirect | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Houlton ScottSee Remarks | Sale | −14.8K | $30.61 | $454K | 23.1Kdirect | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Gennadios AristipposSee Remarks | Sale | −1,470 | $30.61 | $45K | 8,651direct | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Gennadios AristipposSee Remarks | Sale | −4,375 | $30.61 | $134K | 8,651direct | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Gennadios AristipposSee Remarks | Sale | −5,057 | $30.61 | $155K | 8,651direct | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Gennadios AristipposSee Remarks | Sale | −13.1K | $30.61 | $400K | 8,651direct | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Gennadios AristipposSee Remarks | Sale | −883 | $30.61 | $27K | 8,651direct | Apr 1, 2015 | Apr 3, 2015 | Form 4 ↗ |
| Leonard StephenSee Remarks | Sale | −31.0K | $30.13 | $934K | 44.5Kdirect | Mar 27, 2015 | Mar 31, 2015 | Form 4 ↗ |
| Blackstone Holdings III GP Management L.L.C.10% owner | Sale | −24.0M | — | — | 40.6Mindirect | Mar 9, 2015 | Mar 11, 2015 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −480 | $27.40 | $13K | 15.4Kdirect | Feb 17, 2015 | Feb 19, 2015 | Form 4 ↗ |
| Johnson SharonSee Remarks | Sale | −24.2K | $27.40 | $663K | 15.4Kdirect | Feb 17, 2015 | Feb 19, 2015 | Form 4 ↗ |
| Kurt NielsenSee Remarks | Sale Amended | −29.1K | $27.41 | $797K | 23.7Kdirect | Feb 17, 2015 | Feb 19, 2015 | Form 4 ↗ |
| Kurt NielsenSee Remarks | Sale | −20.0K | $27.41 | $548K | 23.7Kdirect | Feb 17, 2015 | Feb 19, 2015 | Form 4 ↗ |
| Houlton ScottSee Remarks | Sale | −13.1K | $27.42 | $360K | 18.3Kdirect | Feb 17, 2015 | Feb 18, 2015 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →